125 related articles for article (PubMed ID: 3791480)
1. Netilmicin pharmacokinetics in uremic patients undergoing hemodialysis.
Scatizzi A; Basile C; Strippoli P; Di Maggio A; Orbello G; Lodeserto C; Triarico A; Mingrone G; Longo S; Curino E
Chemioterapia; 1986 Oct; 5(5):327-9. PubMed ID: 3791480
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of netilmicin during hemodialysis: comparison of four artificial kidneys.
Herrero A; Rius Alarcó F; García-Díez JM; Mahiques E; Domingo JV
Int J Clin Pharmacol Ther Toxicol; 1988 Dec; 26(12):605-9. PubMed ID: 3209278
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of netilmicin in hypertonic hemodiafiltration and standard hemodialysis.
Basile C; Di Maggio A; Curino E; Scatizzi A
Clin Nephrol; 1985 Dec; 24(6):305-9. PubMed ID: 4075599
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of netilmicin in renal insufficiency and hemodialysis.
Herrero A; Rius Alarcó F; García Díez JM; Mahiques E; Domingo JV
Int J Clin Pharmacol Ther Toxicol; 1988 Feb; 26(2):84-7. PubMed ID: 3045024
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of dyphylline elimination by uremic patients.
Lee CC; Wang LH; Majeske BL; Marbury TC
J Pharmacol Exp Ther; 1981 May; 217(2):340-4. PubMed ID: 7229976
[TBL] [Abstract][Full Text] [Related]
6. Aminoglycoside redistribution phenomenon after hemodialysis: netilmicin and tobramycin.
Halstenson CE; Berkseth RO; Mann HJ; Matzke GR
Int J Clin Pharmacol Ther Toxicol; 1987 Jan; 25(1):50-5. PubMed ID: 3557729
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of netilmicin in patients with renal impairment and in patients on dialysis.
Luft FC; Brannon DR; Stropes LL; Costello RJ; Sloan RS; Maxwell DR
Antimicrob Agents Chemother; 1978 Sep; 14(3):403-7. PubMed ID: 708018
[TBL] [Abstract][Full Text] [Related]
8. Absorption and disposition of ibuprofen in hemodialyzed uremic patients.
Senekjian HO; Lee CS; Kuo TH; Au DS; Krothapalli R
Eur J Rheumatol Inflamm; 1983; 6(2):155-62. PubMed ID: 6673979
[TBL] [Abstract][Full Text] [Related]
9. Effect of hemodialysis on ceftazidime pharmacokinetics.
Nikolaidis P; Tourkantonis A
Clin Nephrol; 1985 Sep; 24(3):142-6. PubMed ID: 3899438
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of urinary-tract infections with netilmicin (author's transl)].
Weissbach L; Prehn U; Krasemann C; Gillissen J; Mette U
Dtsch Med Wochenschr; 1978 Dec; 103(49):1961-5. PubMed ID: 720228
[TBL] [Abstract][Full Text] [Related]
11. Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.
De Martin S; Orlando R; Bertoli M; Pegoraro P; Palatini P
Clin Pharmacol Ther; 2006 Dec; 80(6):597-606. PubMed ID: 17178261
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of recombinant hirudin in hemodialyzed end-stage renal failure patients.
Vanholder R; Camez A; Veys N; Van Loo A; Dhondt AM; Ringoir S
Thromb Haemost; 1997 Apr; 77(4):650-5. PubMed ID: 9134637
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of netilmicin in premature infants.
Kuhn RJ; Nahata MC; Powell DA; Bickers RG
Eur J Clin Pharmacol; 1986; 29(5):635-7. PubMed ID: 3956569
[TBL] [Abstract][Full Text] [Related]
14. The effect of hemodialysis on piperacillin pharmacokinetics.
Heim-Duthoy KL; Halstenson CE; Abraham PA; Matzke GR
Int J Clin Pharmacol Ther Toxicol; 1986 Dec; 24(12):680-4. PubMed ID: 3818147
[TBL] [Abstract][Full Text] [Related]
15. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of fosfomycin in hemodialyzed patients.
Bouchet JL; Quentin C; Albin H; Vinçon G; Guillon J; Martin-Dupont P
Clin Nephrol; 1985 May; 23(5):218-21. PubMed ID: 4006330
[TBL] [Abstract][Full Text] [Related]
17. Resting skeletal muscle membrane potential as an index of uremic toxicity. A proposed new method to assess adequacy of hemodialysis.
Cotton JR; Woodard T; Carter NW; Knochel JP
J Clin Invest; 1979 Mar; 63(3):501-6. PubMed ID: 429569
[TBL] [Abstract][Full Text] [Related]
18. Prevention of clot formation during haemodialysis using the direct thrombin inhibitor melagatran in patients with chronic uraemia.
Attman PO; Ottosson P; Samuelsson O; Eriksson UG; Eriksson-Lepkowska M; Fager G
Nephrol Dial Transplant; 2005 Sep; 20(9):1889-97. PubMed ID: 15928099
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of netilmicin in renal insufficiency and haemodialysis.
Pechere JC; Dugal R; Pechere MM
Clin Pharmacokinet; 1978; 3(5):395-406. PubMed ID: 699461
[TBL] [Abstract][Full Text] [Related]
20. Influence of type of dialyzer on the pharmacokinetics of amikacin.
Lanao JM; Dominguez-Gil A; Tabernero JM; Macias JF
Int J Clin Pharmacol Ther Toxicol; 1983 Apr; 21(4):197-202. PubMed ID: 6862725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
